Position in ADCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$769,672
-$142,237 QoQ
Shares Held
719,320
+195.8% QoQ
Ownership
0.563%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 113 holders
Holding Since
Sep 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. ADCT ranks #36 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,267,706 | $101,074,198 | |
| 2 | ALKS |
Alkermes plc.
|
1,312,031 | $68,750,423 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,804,758 | $61,813,683 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
1,950,332 | $49,479,922 | |
| 5 | ZTS |
Zoetis Inc.
|
537,515 | $38,625,827 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
569,756 | $36,435,896 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
767,668 | $35,704,237 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,049,467 | $32,852,956 |
All Filings in ADCT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $769,672 | 719,320 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $911,909 | 243,176 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $928,640 | 263,071 | Shares | Defined | 2026-02-17 | |
| 2024-09-30 | $895,365 | 284,243 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $833,329 | 263,712 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $120,875 | 26,921 | Shares | Defined | 2024-05-15 | |
| 2020-09-30 | $914,251 | 27,713 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||